Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Rashidi, S. (Sajad) | - |
dc.creator | Fernández-Rubio, C. (Celia) | - |
dc.creator | Manzano-Román, R. (Raúl) | - |
dc.creator | Mansouri, R. (Reza) | - |
dc.creator | Shafiei, R. (Reza) | - |
dc.creator | Ali-Hassanzadeh, M. (Mohammad) | - |
dc.creator | Barazesh, A. (Afshin) | - |
dc.creator | Karimazar, M. (Mohammadreza) | - |
dc.creator | Hatam, G. (Gholamreza) | - |
dc.creator | Nguewa, P.A. (Paul Alain) | - |
dc.date.accessioned | 2021-09-28T10:21:12Z | - |
dc.date.available | 2021-09-28T10:21:12Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Rashidi, S. (Sajad); Fernández-Rubio, C. (Celia); Manzano-Román, R. (Raúl); et al. "Potential therapeutic targets shared between leishmaniasis and cancer". Parasitology. 148, 2021, 655 - 671 | es_ES |
dc.identifier.issn | 1469-8161 | - |
dc.identifier.uri | https://hdl.handle.net/10171/62083 | - |
dc.description.abstract | The association of leishmaniasis and malignancies in human and animal models has been highlighted in recent years. The misdiagnosis of coexistence of leishmaniasis and cancer and the use of common drugs in the treatment of such diseases prompt us to further survey the molecular biology of Leishmania parasites and cancer cells. The information regarding common expressed proteins, as possible therapeutic targets, in Leishmania parasites and cancer cells is scarce. Therefore, the current study reviews proteins, and investigates the regulation and functions of several key proteins in Leishmania parasites and cancer cells. The up- and down-regulations of such proteins were mostly related to survival, development, pathogenicity, metabolic pathways and vital signalling in Leishmania parasites and cancer cells. The presence of common expressed proteins in Leishmania parasites and cancer cells reveals valuable information regarding the possible shared mechanisms of pathogenicity and opportunities for therapeutic targeting in leishmaniasis and cancers in the future. | es_ES |
dc.description.sponsorship | PN gratefully acknowledges support provided by Fundación La Caixa (LCF/PR/PR13/11080005) and Fundación Caja Navarra, Gobierno Navarra Salud (12/2017), Fundación Roviralta, Ubesol, Government of Navarre, Laser Ebro and Inversores Garcilaso de la Vega S.L. This study was supported by the National Institute for Medical Research Development (NIMAD), Tehran, Iran, grant number 971405. | es_ES |
dc.language.iso | spa | es_ES |
dc.publisher | Cambridge University Press | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Cancer | es_ES |
dc.subject | Common protein | es_ES |
dc.subject | Drug | es_ES |
dc.subject | Leishmaniasis | es_ES |
dc.subject | Therapeutic target | es_ES |
dc.title | Potential therapeutic targets shared between leishmaniasis and cancer | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.identifier.doi | 10.1017/S0031182021000160 | - |
dadun.citation.endingPage | 671 | es_ES |
dadun.citation.publicationName | Parasitology | es_ES |
dadun.citation.startingPage | 655 | es_ES |
dadun.citation.volume | 148 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.